EpiBiome Lands $6M For Agricultural Antibiotics Alternatives
South San Francisco-based EpiBiome, which says it is developing an alternative to small molecule antibiotics for agriculture, has raised $6M in a Series A funding round today. The funding came from Viking Global Investors via the Illumina Accelerator, Boost Capital, Matrix Capital Management, Alexandria Venture Investments, SV Tech Ventures and China Rock Capital Management. The company says it is using bacteriophage-based therapy to provide a natural alternative to antibiotics in agriculture, which has come under fire for contributing to antibiotics resistance in humans. The startup is led by Dr. Nick Conley.
posted on Thursday, February 4, 2016
Related companies:
EpiBiome, Inc.
Related stories:
> EpiBiome Finds $1M In Debt Funding
> Forest Labs Buys Cerexa For $480M
> MicuRx Pharmaceuticals Gets $55M For Antibiotics Development
> TerrAvion Lands $10M
> Achaogen Takes $56M In Series C Round
silicontap.com Home